Episode

Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1

Podcast
Neurology® Podcast
Published
Jul 27, 2026
Duration seconds
1584
Processing state
not_requested
Canonical source
https://neurology.libsyn.com/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-1
Audio
https://traffic.libsyn.com/secure/neurology/Neurology_Podcast_-_July_28th_2026_v3.mp3?dest-id=937793
JSON
/v1/public/podcasts/neurology-podcast-635512/episodes/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-1
Markdown
/podcast/neurology-podcast-635512/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-1.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/neurology-podcast-635512/episodes/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-1/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/neurology-podcast-635512/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-1.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting . Read more about the Fenebrutinib Trial . Disclosures can be found at Neurology.org .